肺康复运动训练对稳定期COPD合并肺心病患者的辅助治疗作用观察

摘要

Objective To explore the therapeutic effect of pulmonary rehabilitation on patients of stable COPD with pulmonary heart disease.Method The 200 patients with COPD combined with pulmonary heart disease were randomly divided into the experimental group and the control group, which were selected from the hospital respiratory department from January 1, 2014, to December 31, 2016. All patients underwent routine treatment and health education, and the experimental group was given pulmonary rehabilitation on this basis. Detect and collect the date of 6 minutes walking distance (6MWD), PCT, D-dimer, HCT, CTnI, plasma BNP, pulmonary artery pressure, Tei index before and after 6 months after treatment in patients.Result There was no statistically significant difference between the two groups before treatment (P>0.05). The differences of 6MWD, PCT, d-dimer, HCT, CTnI, plasma BNP, Tei index and pulmonary artery pressure were statistically significant in each group of patients before and after treatment (P<0.05). At the same time, compared with 6MWD, PCT, d-dimer, HCT, CTnI, plasma BNP and Tei index, the difference was statistically significant (P<0.05). There was a decrease in pulmonary artery pressure in both groups after treatment, but there was no statistically significant difference between the groups (P<0.05). Conclusion Pulmonary rehabilitation is an effective adjuvant therapy for patients with COPD combined with pulmonary heart disease. It can improve patients' motor ability and improve the quality of life of patients.%目的 探讨肺康复运动训练对稳定期慢性阻塞性肺疾病(COPD)合并肺心病患者的辅助治疗效果.方法 选择2014年1月1日至2016年12月31日在本院呼吸内科就诊的200例COPD合并肺心病稳定期患者,随机分为观察组及对照组,两组患者均采取常规治疗及健康宣教,观察组在此基础上联合肺康复运动训练.对治疗前、治疗后6个月后两组患者的6分钟步行距离(6MWD)、降钙素原、D-二聚体、红细胞比容(Hct)、血清肌钙蛋白,血浆脑钠肽(BNP)水平、肺动脉收缩压及心脏Tei指数进行比较分析.结果 治疗前两组各项生理指标比较差异无显著性(P>0.05);治疗后两组患者6MWD、降钙素原、D-二聚体、Hct、血清肌钙蛋白、血浆BNP水平、心脏Tei指数、肺动脉收缩压与治疗前比较差异均有显著性(P<0.05),同时组间比较6MWD、降钙素原、D-二聚体、Hct、血清肌钙蛋白,血浆BNP水平、心脏Tei指数,差异也有显著性(P<0.05),治疗后两组肺动脉收缩压较治疗前均有下降趋势,但组间比较差异无显著性(P>0.05).结论 肺康复运动训练对于COPD合并肺心病患者是一种有效的辅助治疗方法,能够提高患者的运动耐力.